本课题部分由四川省卫生厅科研基金资助（962019）
参考文献
［1］Ogata K, Linzer BA, Zuberi RI, et al. Activity of defensins from human neutrophilic granulocytes against Mycobacterium avium－ Mycobacterium intracellulare. Infect Immun， 1992， 60:4720－ 4725.
［2］Selsted ME, Szklarek D,Lehrer RI. Purification and antibacterial activity of antimicrobial peptides of rabbit granulocytes. Infect Immun， 1984， 45: 150－ 154.
［3］Lehrer RI, Ganz T, Szklarek D, et al. Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations. J Clin Invest， 1988， 81:1829－ 1835.
［4］Alcouloumre MS, Ghannoum MA, Ibrahim AS, et al. Fungicidal properties of defensin NP－ 1 and activity against Cryptococcus neoformans in vitro. Antimicrob Agents Chemother， 1993， 37:2628－ 2632.
［5］吴琦，徐罗玲，王伯瑶，等.人中性粒细胞防御素的分离纯化.中国免疫学杂志，1993，9:106－109.
［6］Lehrer RI, Szklarek D.Mechanisms of microbicidal activity by defensins. Clin Res， 1987， 35:616－ 619.
［7］Lehrer RI, Szklarek D, Ganz T, et al. Correlation of binding of rabbit granulocyte peptides to Candida albicans with candidacidal activity. Infect Immun， 1985， 49:207－ 211.
［8］Wimley WC, Selsted ME, White SH. Interactions between human defensins and lipid bilayers: Evidence for formation of multimeric pores. Protein Sci， 1994,3:1362－ 1373.
